Cogent Biosciences Inc
(COGT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 2,220 | 2,140 | 2,331 | 2,079 | 1,827 |
| Gross Profit | 2,220 | 2,140 | 2,331 | 2,079 | 1,827 |
| Operating Expenses | 9,206 | 9,020 | 9,501 | 8,112 | 7,896 |
| Operating Income | -6,986 | -6,880 | -7,170 | -6,033 | -6,069 |
| Other Income | 251 | 178 | 170 | 170 | 130 |
| Pre-tax Income | -6,735 | -6,702 | -7,000 | -5,863 | -5,939 |
| Net Income Continuous | -6,735 | -6,702 | -7,000 | -5,863 | -5,939 |
| Net Income | $-6,735 | $-6,702 | $-7,000 | $-5,863 | $-5,939 |
| EPS Basic Total Ops | -2.64 | -2.64 | -2.76 | -2.32 | -2.32 |
| EPS Basic Continuous Ops | -2.64 | -2.62 | -2.75 | -2.30 | -2.33 |
| EPS Diluted Total Ops | -2.64 | -2.64 | -2.76 | -2.32 | -2.32 |
| EPS Diluted Continuous Ops | -2.64 | -2.62 | -2.75 | -2.30 | -2.33 |
| EBITDA(a) | $-6,668 | $-6,574 | $-6,865 | $-5,744 | $-5,789 |